Document:

VOTING
AGREEMENT

 

This
VOTING AGREEMENT (this “Agreement”) is entered into as of July 15,
2019 by and among Ampersand 2018 Limited Partnership, a Delaware limited partnership (including its successors and assigns, “Purchaser”)
and [●], an individual (“Stockholder”).

 

RECITALS

 

WHEREAS,
as of the date hereof, Stockholder is the legal and beneficial owner (as defined in Rule 13d-3 of the Exchange Act, which
meaning will apply for all purposes of this Agreement whenever the term “beneficial” or “beneficially”
is used) of the shares of common stock, par value of $0.01 per share (the “Common Stock”),
of Interpace Diagnostics Group, Inc., a Delaware corporation (the “Company”),
such Common Stock together with any other shares of Common Stock or other equity interests, in each case, over which Stockholder
acquires beneficial ownership during the period from the date hereof until the termination of this Agreement are collectively
referred to herein as the “Subject Shares”;

 

WHEREAS,
concurrently with the execution and delivery of this Agreement, the Company and the Purchaser are entering into a Securities Purchase
Agreement (the “Securities Purchase Agreement”), pursuant to which
the Company will issue and sell to the Purchaser, and the Purchaser will purchase from the Company, shares of convertible preferred
stock of the Company designated as Series A Convertible Preferred Stock, par value $0.01 per share (the “Series
A Shares”), and shares of convertible preferred stock of the Company designated as Series A-1 Convertible Preferred
Stock, par value $0.01 per share (the “Series A-1 Shares” and together with
the Series A Shares, the “Preferred
Shares”);

 

WHEREAS,
it is expected that, in accordance with the terms of an investor rights agreement (the “Investor Rights Agreement”)
required to be entered into by the Company and the Purchaser pursuant to the Securities Purchase Agreement (subject to the terms
and conditions thereof), the Company shall make certain proposals to holders of Common Stock requesting such stockholders’
approval of (i) potential issuances of Common Stock in connection with conversions of Series A Shares, including the Series A
Shares issuable upon conversion of the Series A-1 Shares, pursuant to the terms of the Certificate of Designation (“Conversion
Issuances”) and potential Preemptive Rights Issuances (as defined below); and

 

WHEREAS,
as an inducement to the Purchaser’s willingness to enter into the Securities Purchase Agreement, the Purchaser and Stockholder
are entering into this Agreement.

 

    	 

     

    

 

AGREEMENT

 

NOW,
THEREFORE, in consideration of the foregoing and the respective representations, warranties, covenants and agreements set forth
herein, the parties agree as follows:

 

ARTICLE
I

 

DEFINITIONS

 

Section
1.1 Capitalized Terms. For purposes of this Agreement, capitalized terms used and not defined herein shall have the respective
meanings ascribed to them in the Securities Purchase Agreement, the Certificate of Designation (as defined in the Securities Purchase
Agreement) and/or the Investor Rights Agreement, as applicable.

 

ARTICLE
II

 

VOTING
AGREEMENT

 

Section
2.1 Agreement to Vote the Subject Shares During the Voting Period. Stockholder hereby agrees that, during the period from
the date hereof through the termination of this Agreement in its entirety pursuant to Section 5.1 (the “Voting
Period”), at any meeting (whether annual or special and each adjourned, reconvened or postponed meeting) of the
Company’s stockholders, however called, and on every action or approval by written consent or consents of the Company stockholders
with respect to any of the following matters, Stockholder shall, if a meeting is held, appear at the meeting, in person or by
proxy, or otherwise cause its Subject Shares to be counted as present thereat for purposes of establishing a quorum, and it shall
vote or consent (or cause to be voted or consented), irrevocably and unconditionally, in person or by proxy, all of its Subject
Shares:

 

(a)
in favor of any proposal to approve the Conversion Issuances and/or the Preemptive Rights Issuances;

 

(b)
in favor of any additional approvals of the stockholders of the Company required under the Company Organizational Documents (as
defined in the Securities Purchase Agreement) or any regulation or rule of The Nasdaq Capital Market (or any other Trading Market
(as defined in the Securities Purchase Agreement) on which the Common Stock is listed or quoted for trading on the date in question),
in each case in connection with the Conversion Issuances and/or the Preemptive Rights Issuances;

 

(c)
at the request of the Purchaser, in favor of adoption of any other proposal that the Company’s Board of Directors (the “Board”)
has (i) determined is reasonably necessary to facilitate the Conversion Issuances and/or the Preemptive Rights Issuances in accordance
with the terms of the Securities Purchase Agreement, the Certificate of Designation or Investor Rights Agreement or any other
matter contemplated thereby and (ii) recommended by the Board to be adopted by the stockholders of the Company; and

 

(d)
against any other action, agreement or transaction, that is intended, or the effect of which could reasonably be expected, to
impede, interfere with, delay, postpone, discourage or adversely affect the approvals and actions in Sections 2.1(a), (b)
and (c) or completion of the transactions contemplated by the Securities Purchase Agreement or Investor Rights Agreement.

 

    	2

     

    

 

Section
2.2 Preemptive Rights Issuances. If (i) any of the Investor Parties (as defined in the Investor Rights Agreement) desires
to exercise preemptive rights to acquire capital stock of the Company pursuant to Section 7 of the Investor Rights Agreement and
(ii) the issuance of such capital stock to any such Investor Party (a “Preemptive Rights Issuance”) would require
approval of the stockholders of the Company under the Company Organizational Documents or any regulation or rule of The Nasdaq
Capital Market (or any other Trading Market on which the Common Stock is listed or quoted for trading on the date in question),
the Stockholder irrevocably and unconditionally agrees during the Voting Period to vote, in person or by proxy, at any meeting
(whether annual or special and each adjourned, reconvened or postponed meeting) of the Company’s stockholders, however called,
or to act by written resolution of the Company’s stockholders (if applicable) with respect to, all of its Subject Shares
or other equity securities of the Company having the right to vote in favor of such issuance beneficially owned by it, in favor
of such issuance.

 

Section
2.3 Irrevocable Proxy and Power of Attorney. Stockholder hereby constitutes and appoints as the proxy of Stockholder and
hereby grants a power of attorney to any authorized designee of Purchaser, and each of them, with full power of substitution,
with respect to the matters set forth herein, and hereby authorizes each of them to vote all of the Subject Shares in a manner
which is consistent with the terms of Section 2.1 or Section 2.2, respectively, or to take any other action necessary to give
effect to Section 2.1 or Section 2.2, respectively, if and only if Stockholder (i) fails to vote all of the Subject Shares or
(ii) attempts to vote (whether by proxy, in person or by written consent), any of the Subject Shares in a manner which is inconsistent
with the terms of Section 2.1 or Section 2.2, respectively. Each of the proxy and the power of attorney granted pursuant to the
immediately preceding sentence is given in consideration of the agreements and covenants of Purchaser in connection with the transactions
contemplated by this Agreement and, as such, each is coupled with an interest and shall be irrevocable unless and until this Agreement
terminates pursuant to Section 5.1 hereof. Stockholder hereby revokes any and all previous proxies or power of attorney with respect
to the Subject Shares and shall not hereafter, unless and until this Agreement terminates pursuant to Section 5.1 hereof, purport
to grant any other proxy or power of attorney with respect to any of the Subject Shares, deposit any of the Subject Shares into
a voting trust or enter into any agreement (other than this Agreement), arrangement or understanding with any person, directly
or indirectly, to vote, grant any proxy or give instructions with respect to the voting of any of the Subject Shares, in each
case, with respect to any of the matters set forth herein.

 

ARTICLE
III

 

COVENANTS

 

Section
3.1 Subject Shares.

 

(a)
Stockholder agrees that, until the earlier of the end of the Voting Period and the six (6) month anniversary of the date of this
Agreement, Stockholder will not, directly or indirectly, offer for sale, sell (including short sales), contract to sell, assign,
hypothecate, transfer, tender, pledge, grant a security interest in, encumber, assign or otherwise dispose of (including by gift)
(collectively, a “Transfer”) any Subject Shares, or enter into any
contract, option, or other agreement with respect to, or consent to, a Transfer of, any of the Subject Shares or Stockholder's
voting or economic interest therein. Any attempted Transfer of Subject Shares or any interest therein in violation of this Section
3.1(a) shall be null and void. During the Voting Period, in furtherance of this Agreement, Stockholder hereby authorizes the Company
or its counsel to notify the Company’s transfer agent that there is a stop transfer order with respect to all of the Subject
Shares (and that this Agreement places limits on the voting and transfer of the Subject Shares), subject to the provisions hereof
and provided that any such stop transfer order and notice will immediately be withdrawn and terminated by the Company following
the termination of this Agreement.

 

    	3

     

    

 

(b)
Stockholder agrees that all shares of Common Stock that Stockholder purchases, acquires the right to vote, or otherwise acquires
beneficial ownership of, but excluding shares of Common Stock underlying unexercised Options (as defined below), during the Voting
Period shall be subject to the terms and conditions of this Agreement and shall constitute Subject Shares for all purposes of
this Agreement.

 

(c)
In the event of a share dividend or distribution, or any change in the Common Stock by reason of any share dividend or distribution,
split-up, recapitalization, combination, conversion, exchange of shares or similar transaction, the term “Subject
Shares” shall be deemed to refer to and include the Subject Shares as well as all such share dividends and distributions
and any securities into which or for which any or all of the Subject Shares may be changed or exchanged or which are received
in such transaction.

 

(d)
Stockholder shall, during the Voting Period, notify the Purchaser of the number of any new Common Shares or other securities entitling
the holder thereof to vote or give consent with respect to the matters set forth in Article II acquired by Stockholder, if any,
after the date hereof.

 

Section
3.2 Stockholder’s Capacity[; Stockholder Designees]. All agreements and understandings made herein shall be
made solely in Stockholder’s capacity as a holder of the Subject Shares and not in any other capacity. [For the avoidance
of doubt, the parties acknowledge and agree that (i) Stockholder is a member of the Board (in such capacity, the “Stockholder
Director”) and shall be free
to act in his or her capacity as a director of the Company in accordance with such director’s fiduciary duties under the
laws of the state of Delaware, including with respect to any vote cast or written consent given in his or her capacity as a director
of the Company on any matter, (ii) nothing herein shall prohibit or restrict the Stockholder Director from taking any action in
his or her capacity as a director in facilitation of the exercise of such director’s fiduciary duties under the laws of
the state of Delaware and (iii) no action taken by the Stockholder Director acting solely in his or her capacity as a director
of the Company, including any vote cast or written consent given in his or her capacity as a director of the Company on any matter,
shall be deemed to be a breach by Stockholder of this Agreement.]1

 

Section
3.3 Further Assurances. Each of the parties shall, from time to time, use its respective commercially reasonable efforts
to perform, or cause to be performed, such further acts and to execute and deliver, or cause to be executed and delivered, such
additional or further consents, documents and other instruments as may be necessary to vest in another party the power to carry
out and give effect to the provisions of this Agreement.

 

 

1
NTD: Bracketed language to be included only in voting agreements signed by Company directors.

 

    	4

     

    

 

ARTICLE
IV

 

REPRESENTATIONS
AND WARRANTIES

 

Section
4.1 Representations and Warranties of Stockholder. Stockholder hereby represents and warrants to the Purchaser as follows:

 

(a)
Due Organization and Authorization. Stockholder is a natural person. Stockholder has all necessary power and authority
to execute and deliver this Agreement, to perform its obligations hereunder and to consummate the transactions contemplated hereby.
The execution, delivery and performance of this Agreement and the consummation of the transactions contemplated hereby by Stockholder
have been duly authorized by all necessary action on the part of Stockholder. This Agreement has been duly executed and delivered
by Stockholder and (assuming the due authorization, execution and delivery by the Purchaser) constitutes a valid and binding obligation
of Stockholder, enforceable against Stockholder in accordance with its terms, except to the extent enforcement is limited by bankruptcy,
insolvency, fraudulent transfer, reorganization, moratorium and similar laws of general applicability relating to or affecting
creditors’ rights and by general equitable principles.

 

(b)
Ownership of Shares. As of the date hereof, Stockholder is the legal and beneficial owner of the Subject Shares and has
the sole power to vote or cause to be voted such Subject Shares. As of the date hereof, Stockholder does not own or hold any right
to acquire any additional shares of any class of share capital of the Company or other securities of the Company or any interest
therein or any voting rights with respect to any securities of the Company other than (i) the Subject Shares and (ii) the options,
warrants and other rights to acquire additional shares of Common Stock or security exercisable for or convertible into shares
of Common Stock, set forth on the signature page of this Agreement (collectively, “Options”). Stockholder has
good and valid title to the Subject Shares, free and clear of any and all Liens of any nature or kind whatsoever, other than (x)
those created by this Agreement or (y) those imposed under applicable securities laws.

 

(c)
No Conflicts. Other than, in the case of clauses (i) and (ii)(z) below, compliance by Stockholder with the applicable requirements
of the Exchange Act, (i) no filing with any Governmental Entity, and no authorization, consent or approval of any other Person
is necessary for the execution, delivery and performance of this Agreement by Stockholder and the consummation by Stockholder
of the transactions contemplated hereby and (ii) none of the execution, delivery and performance of this Agreement by Stockholder,
the consummation by Stockholder of the transactions contemplated hereby or compliance by Stockholder with any of the provisions
hereof shall result in, or give rise to, a violation or breach of or a default under any of the terms of any contract, understanding,
agreement or other instrument or obligation to which Stockholder is a party or by which Stockholder or any of the Subject Shares
or its assets may be bound or (z) violate any applicable law except as would not reasonably be expected to materially impair
Stockholder’s ability to perform its obligations under this Agreement.

 

    	5

     

    

 

Section
4.2 Representations and Warranties of the Purchaser. Purchaser hereby represents and warrants to Stockholder as follows:

 

(a)
Due Organization and Authorization. Purchaser is duly organized and validly existing under the Laws of its jurisdiction
or organization or formation. Purchaser has all necessary power and authority to execute and deliver this Agreement, to perform
its obligations hereunder and to consummate the transactions contemplated hereby. The execution, delivery and performance of this
Agreement and the consummation of the transactions contemplated hereby by the Purchaser have been duly authorized by all necessary
action on the part of Purchaser. This Agreement has been duly executed and delivered by Purchaser and (assuming the due authorization,
execution and delivery by Stockholder) constitutes a valid and binding obligation of Purchaser, enforceable against Purchaser
in accordance with its terms, except to the extent enforcement is limited by bankruptcy, insolvency, fraudulent transfer, reorganization,
moratorium and similar Laws of general applicability relating to or affecting creditors’ rights and by general equitable
principles.

 

(b)
No Conflicts. Other than, in the case of clauses (i) and (ii)(z) below, compliance by the Purchaser with the applicable
requirements of the Exchange Act, (i) no filing with any Governmental Entity, and no authorization, consent or approval of any
other Person is necessary for the execution, delivery and performance of this Agreement by Purchaser and the consummation by Purchaser
of the transactions contemplated hereby and (ii) none of the execution, delivery and performance of this Agreement by Purchaser,
the consummation by Purchaser of the transactions contemplated hereby or compliance by Purchaser with any of the provisions hereof
shall (x) conflict with or result in any breach of the organizational documents of Purchaser, (y) result in, or give rise to,
a violation or breach of or a default under any of the terms of any contract, understanding, agreement or other instrument or
obligation to which Purchaser is a party or by which Purchaser or any of its assets may be bound or (z) violate any applicable
Law except as would not reasonably be expected to materially impair Purchaser’s ability to perform its obligations under
this Agreement.

 

ARTICLE
V

 

TERMINATION

 

Section
5.1 Termination. This Agreement shall automatically terminate, and neither the Purchaser nor Stockholder shall have any
rights or obligations hereunder and this Agreement shall become null and void and have no effect (other than the parties hereto
remaining responsible for any breaches of this Agreement prior to such termination) upon the earliest to occur of: (i) a written
agreement among the Purchaser and Stockholder to terminate this Agreement pursuant to Section 5.1 or the written request by the
Purchaser delivered to the Stockholder to terminate this Agreement, at which time this Agreement shall be so terminated without
any action required by the Stockholder; (ii) the termination of the Securities Purchase Agreement in accordance with its terms;
(iii) the date on which Stockholder no longer serves as an officer or director of the Company, (iv) the date on which the Investors’
(as defined in the Investor Rights Agreement) obligations under Section 8.10 of the Investor Rights Agreement terminate, (v) five
(5) Business Days following the Requisite Approval Date (as defined below); and (vi) such date to occur after the Issuance Date
(as defined in the Certificate of Designation) in which there are no issued and outstanding Preferred Shares. Notwithstanding
anything to the contrary herein, the provisions of Article VI shall survive the termination of this Agreement. For
purposes of the foregoing, the “Requisite Approval Date” shall be the first date to occur in which (1) the
Nasdaq Approval (as defined in the Certificate of Designation) has been obtained on or prior to such date and remains in full
force and effect on such date and (2) the requisite approval of the stockholders of the Company to pre-approve the Preemptive
Rights Issuances for purposes of allowing the Investor Parties to participate therein in full in compliance with applicable law
and the rules and regulations of The Nasdaq Capital Market (or any other Trading Market on which the Common Stock is listed or
quoted for trading on the date in question) (the approval described in this clause (2), the “Preemptive Approval”)
has been obtained on or prior to such date and remains in full force and effect on such date.

 

    	6

     

    

 

ARTICLE
VI

 

MISCELLANEOUS

 

Section
6.1 Publication. Stockholder hereby permits the Purchaser (and its Affiliates) and the Company to publish and disclose
publicly (including in any documents and schedules filed with the Securities and Exchange Commission) Stockholder’s identity
and ownership of Subject Shares and the nature of its commitments, arrangements and understandings pursuant to this Agreement
as reasonably determined by the Purchaser or the Company, as applicable, to be required under applicable law or under the rules
and regulations of The Nasdaq Capital Market (or any other Trading Market on which the Common Stock is listed or quoted for trading
on the date in question).

 

Section
6.2 Fees and Expenses. Stockholder and the Purchaser shall be responsible for their own fees and expenses (including the
fees and expenses of investment bankers, accountants and counsel) in connection with the entering into and performance under this
Agreement and the consummation of the transactions contemplated hereby.

 

Section
6.3 Amendments, Waivers. This Agreement may not be amended, changed, supplemented, waived or otherwise modified, except
upon the execution and delivery of a written agreement executed by each of the parties hereto; provided, that any amendment,
change, supplement, waiver or other modification that would reasonably be expected to be adverse to the Company shall require
the consent of the Company. The failure of any party hereto to exercise any right, power or remedy provided under this Agreement
or otherwise available in respect hereof at law or in equity, or to insist upon compliance by any other party hereto with its
obligations hereunder, and any custom or practice of the parties at variance with the terms hereof shall not constitute a waiver
by such party of its right to exercise any such or other right, power or remedy or to demand such compliance.

 

    	7

     

    

 

Section
6.4 Notices. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall
be in writing and shall be deemed given and effective on the earliest of (a) the date of transmission, if such notice or communication
is delivered via email (provided the sender does not receive a machine-generated rejection of transmission) at the email address
specified in this Section 6.4 prior to 5:00 P.M., New York City time, on a Business Day, (b) the next Business Day after the date
of transmission, if such notice or communication is delivered via email at the email address specified in this Section 6.3 on
a day that is not a Business Day or later than 5:00 P.M., New York City time, on any Business Day, (c) the Business Day following
the date of mailing, if sent by U.S. nationally recognized overnight courier service with next day delivery specified, or (d)
upon actual receipt by the party to whom such notice is required to be given. The address for such notices and communications
shall be as follows, or such other address as may be designated in writing hereafter, in the same manner, by such Person:

 

If
to Stockholder, to it at:

 

[Name]

[Address]

Attn: [●]

Email: [●]

 

with
a copy to (which copy alone shall not constitute notice):

 

[Name]

[Address]

[Address]

Attn:

Email:

 

If
to the Purchaser, at:

 

Ampersand
2018 Limited Partnership

c/o
Ampersand Capital Partners

55 William Street, Suite 240

Wellesley, MA 02481

Attn: Dana L. Niles, Chief Operating Partner

Email: dln@ampersandcapital.com

 

with
a copy to (which copy alone shall not constitute notice):

 

Goodwin
Procter LLP

100
Northern Avenue

Boston, MA 02210

Attn: James T. Barrett, Esq., and Jocelyn Arel, Esq.

Email: JBarrett@goodwinlaw.com and JArel@goodwinlaw.com

 

Section
6.5 Headings. The headings contained in this Agreement are for reference purposes only and shall not affect in any way
the meaning or interpretation of this Agreement.

 

Section
6.6 Severability. If any term or other provision of this Agreement is invalid, illegal or incapable of being enforced by
any rule of law or public policy, all other conditions and provisions of this Agreement shall nevertheless remain in full force
and effect so long as the economic or legal substance of the transactions contemplated hereby is not affected in any manner adverse
to any party. Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the
parties hereto shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as closely
as possible in an acceptable manner to the end that the transactions contemplated hereby are fulfilled to the fullest extent possible.

 

    	8

     

    

 

Section
6.7 Entire Agreement; Assignment. This Agreement constitutes the entire agreement between the parties with respect to the
subject matter hereof and supersedes all prior agreements and undertakings, both written and oral, between the parties, or any
of them, with respect to the subject matter hereof. This Agreement shall not be assigned by operation of law or otherwise without
the prior written consent of each of the parties.

 

Section
6.8 Parties in Interest. The Company shall be a third party beneficiary under this Agreement and shall be entitled to enforce
this Agreement as if it were a party hereto. This Agreement shall be binding upon and inure solely to the benefit of each party
hereto and the Company, and nothing in this Agreement, express or implied, is intended to or shall confer upon any other Person
any rights, benefits or remedies of any nature whatsoever under or by reason of this Agreement.

 

Section
6.9 Interpretation. When a reference is made in this Agreement to a Section or Exhibit, such reference shall be to a Section
of, or an Exhibit to, this Agreement unless otherwise indicated. The headings contained in this Agreement are for reference purposes
only and shall not affect in any way the meaning or interpretation of this Agreement. Unless otherwise indicated to the contrary
herein by the context or use thereof: (i) the words, “herein,” “hereto,” “hereof” and words
of similar import refer to this Agreement as a whole, including the Schedules and exhibits, and not to any particular section,
subsection, paragraph, subparagraph or clause contained in this Agreement; (ii) masculine gender shall also include the feminine
and neutral genders, and vice versa; (iii) words importing the singular shall also include the plural, and vice versa; (iv) the
words “include,” “includes” or “including” shall be deemed to be followed by the words “without
limitation”; (v) financial terms shall have the meanings given to such terms under GAAP unless otherwise specified herein;
(vi) references to “$” or “dollar” or “US$” shall be references to United States dollars;
(vi) where the context permits, the use of the term “or” will be non-exclusive and equivalent to the use of the term
“and/or”; (vii) the word “extent” in the phrase “to the extent” shall mean the degree to which
a subject or other thing extends, and such phrase shall not mean simply “if”; and (viii) if any action under this
Agreement is required to be done or taken on a day that is not a Business Day or on which a government office is not open with
respect to which a filing must be made, then such action shall be required to be done or taken not on such day but on the first
succeeding Business Day thereafter. Any agreement, instrument or statute defined or referred to herein or in any agreement or
instrument that is referred to herein means such agreement, instrument or statute as from time to time amended, modified or supplemented,
including (in the case of agreements or instruments) by waiver or consent and (in the case of statutes) by succession of comparable
successor statutes and references to all attachments thereto and instruments incorporated therein. References to a Person are
also to its permitted assigns and successors. The parties hereto have participated jointly in the negotiation and drafting of
this Agreement and, in the event an ambiguity or question of intent or interpretation arises, this Agreement shall be construed
as jointly drafted by the parties hereto and no presumption or burden of proof shall arise favoring or disfavoring any party hereto
by virtue of the authorship of any provision of this Agreement.

 

    	9

     

    

 

Section
6.10 Governing Law; Jurisdiction; Waiver of Jury Trial. This Agreement will be governed by and construed in accordance
with the laws of the State of Delaware, without giving effect to principles or rules of conflict of laws to the extent such principles
or rules would require or permit the application of laws of another jurisdiction. The parties hereby irrevocably and unconditionally
consent to submit to the exclusive jurisdiction of the state and federal courts located in the State of Delaware for any actions,
suits or proceedings arising out of or relating to this Agreement and the transactions contemplated hereby. The parties hereby
irrevocably and unconditionally consent to the jurisdiction of such courts (and of the appropriate appellate courts therefrom)
in any such action, suit or proceeding and irrevocably waive, to the fullest extent permitted by law, any objection that they
may now or hereafter have to the laying of the venue of any such action, suit or proceeding in any such court or that any such
action, suit or proceeding which is brought in any such court has been brought in an inconvenient forum. Process in any such action,
suit or proceeding may be served on any party anywhere in the world, whether within or without the jurisdiction of any such court.
Without limiting the foregoing, each party agrees that service of process on such party as provided in this Section 6.10 shall
be deemed effective service of process on such party. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES ANY AND ALL RIGHT TO
TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATED TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY.

 

Section
6.11 Specific Performance. The parties agree that irreparable damage would occur in the event that any of the provisions
of this Agreement were not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed
that, without the necessity of posting bond or other undertaking, the parties shall be entitled to specific performance of the
terms hereof, this being in addition to any other remedies to which they are entitled at law or equity, and in the event that
any action or suit is brought in equity to enforce the provisions of this Agreement, and no party will allege, and each party
hereby waives, the defense or counterclaim that there is an adequate remedy at law.

 

Section
6.12 No Partnership, Agency or Joint Venture. This Agreement is intended to create a contractual relationship between Stockholder
and the Purchaser and is not intended to create, and does not create, any agency, partnership, joint venture or any like relationship
between or among the parties hereto. Without limiting the generality of the foregoing sentence, no Purchaser or its affiliates
shall be deemed to beneficially own any security solely as a result of the Purchaser’s execution of this Agreement, and
Stockholder (i) is entering into this Agreement solely on its own behalf and Stockholder shall not have any liability (regardless
of the legal theory advanced) for any breach of any similar agreement by any other Stockholder of the Company and (ii) by entering
into and performing under this Agreement does not intend to form a “group” for purposes of Rule 13d-5(b)(1) of the
Exchange Act or any other similar provision of applicable Law.

 

Section
6.13 Counterparts. This Agreement may be executed in separate counterparts, each of which shall be considered one and the
same agreement and shall become effective when each of the parties has delivered a signed counterpart to the other parties, it
being understood that all parties need not sign the same counterpart. Such counterpart executions may be transmitted to the parties
by facsimile transmission or electronic “.pdf”, which shall have the full force and effect of an original signature.

 

    	10

     

    

 

Section
6.14 Holdback & Lock-Up. If any sale of Registrable Securities (as defined in the Investor Rights Agreement) shall
be effected by means of an underwritten offering, the Stockholder agrees that (a) it shall be a Lock-Up Party (as defined in the
Investor Rights Agreement) so long as a Purchaser is a Lock-Up Party, (b) it shall not effect any public sale or distribution
of any of the Company’s securities (except as part of such underwritten offering), including any sale pursuant to Rule 144
under the Securities Act of 1933 or by entering into any swap, hedge or other arrangement that transfers, in whole or in part,
the economic consequence of ownership of such securities, during the ten (10) Business Days prior to, and continuing for ninety
(90) Business Days after, the date of the pricing of such underwritten offering (unless the underwriters, the Company and the
Purchaser agree on a different time period) and (c) it shall enter into a customary “lock-up” agreement in favor of
the underwriters. The foregoing notwithstanding, no Lock-Up Party shall be required to terminate an existing 10b5-1 plan or to
cease sales under any such plan. No Stockholder shall be released from any obligation under any agreement, arrangement or understanding
entered into with respect to this Section 6.14 unless the Purchaser is also released.

 

[Signature
page follows]

 

    	11

     

    

 

IN
WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed and delivered as of the date first above written.

 

	 	STOCKHOLDER:
	 	 
	 	 
	 	Name:

 

	 	Number
                                         of shares of

                                         Common Stock

                                         beneficially owned as of

                                         the date of this Agreement:

        
	

                                         

        

	 	 	 
	 	Number
                                         of Options

                                         beneficially owned as of

                                         the date of this Agreement:

        
	

                                         

        

 

[Signature
Page to Voting Agreement]

 

    	 

     

    

 

	 	PURCHASER:
	 	 	 
	 	Ampersand
    2018 Limited Partnership
	 	 	 
	 	By:	AMP-18
    Management Company Limited Partnership, its General Partner
	 	 	 
	 	By:	AMP-18
    MC LLC, its General Partner
	 	 	 
	 	By:	 
	 	Name:	Herbert
    H. Hooper
	 	Title:	Managing
    Member

 

[Signature
Page to Voting Agreement]Exhibit 4.2

		
			DESCRIPTION OF CAPITAL STOCK OF
		

		
			RESOURCES CONNECTION, INC.
		

		
			﻿
		

		
			This following is a summary of the rights of our capital stock, certain provisions of our amended and restated certificate of incorporation (our “certificate of incorporation”), our third amended and restated bylaws (our “bylaws”), and certain provisions of applicable law. The following description is only a summary and is qualified by reference to our certificate of incorporation and our bylaws. Our certificate of incorporation is filed as Exhibit 10.21 to our Quarterly Report on Form 10-Q for the quarter ended November 30, 2014 filed with the Securities and Exchange Commission (the “SEC”) on January 6, 2005. Our bylaws are filed as Exhibit 3.1 to our Current Report on Form 8-K filed with the SEC on August 31, 2015. 
		

		
			﻿
		

		
			Authorized Capitalization
		

		
			﻿
		

		
			Our authorized capital stock consists of:
		

		
			﻿
		

			
	
			
				 ·
			

			
	
			
			70,000,000 shares of common stock, $0.01 par value per share; and

			
	
			
				 ·
			

			
	
			
			5,000,000 shares of preferred stock, $0.01 par value per share.

		
			﻿
		

		
			As of July 8, 2019, 63,312,814 shares of our common stock were issued, 31,847,394 shares of our common stock were outstanding, and no shares of preferred stock were issued and outstanding. 
		

		
			﻿
		

		
			Common Stock
		

		
			﻿
		

		
			Under our certificate of incorporation, the holders of common stock are entitled to one vote per share on all matters to be voted on by the stockholders. After payment of any dividends due and owing to the holders of preferred stock, holders of common stock are entitled to receive dividends declared by the board of directors out of funds legally available for dividends. In the event of our liquidation, dissolution or winding up, holders of common stock are entitled to share in all assets remaining after payment of liabilities and liquidation preferences of outstanding shares of preferred stock. Holders of common stock have no preemptive, conversion, subscription or other rights. There are no redemption or sinking fund provisions applicable to the common stock. All outstanding shares of common stock are fully paid and nonassessable.
		

		
			﻿
		

		
			Preferred Stock
		

		
			﻿
		

		
			Under our certificate of incorporation, the board of directors has the authority, without further action by stockholders, to issue up to 5,000,000 shares of preferred stock. The board of directors may issue preferred stock in one or more series and may determine the rights, preferences, privileges, qualifications and restrictions granted to or imposed upon the preferred stock, including dividend rights, conversion rights, voting rights, rights and terms of redemption, liquidation preferences and sinking fund terms, any or all of which may be greater than the rights of the common stock. The issuance of preferred stock could adversely affect the voting power of holders of common stock and reduce the likelihood that common stockholders will receive dividend payments and payments upon liquidation. The issuance of preferred stock could also have the effect of decreasing the market price of the common stock and could delay, deter or prevent a change in control of our company. However, is not possible to state the actual effect of the issuance of any shares of our preferred stock on the rights of holders of our common stock until our board of directors determines the specific rights attached to that class or series of preferred stock.
		

		
			﻿
		

		

		

		 

 

		Anti-Takeover Effects of Delaware Law and Our Certificate of Incorporation and Bylaw Provisions
		

		
			﻿
		

		
			Our certificate of incorporation and bylaws contain certain provisions that may make it more difficult to acquire control of us by means of a tender offer, open market purchase, proxy contest or otherwise. These provisions, summarized below, are expected to discourage certain types of coercive takeover practices and takeover bids that our board of directors may consider inadequate and to encourage persons seeking to acquire control of our company to first negotiate with our board of directors.  We believe that the benefits of increased protection of our ability to negotiate with the proponent of an unfriendly or unsolicited proposal to acquire or restructure our company outweigh the disadvantages of discouraging takeover or acquisition proposals because, among other things, negotiation of these proposals could result in an improvement of their terms.
		

		
			﻿
		

		
			Set forth below is a summary of the relevant provisions of our certificate of incorporation and bylaws and certain applicable sections of the General Corporation Law of the State of Delaware (the “DGCL”). For additional information we refer you to the provisions of our certificate of incorporation, our bylaws and those sections of the DGCL.
		

		
			﻿
		

		
			Delaware Anti-Takeover Statute
		

		
			﻿
		

		
			We are governed by the provisions of Section 203 of the DGCL.  Subject to certain exceptions, Section 203 of the DGCL prohibits a public Delaware corporation from engaging in a “business combination” (as defined in such section) with an “interested stockholder” (defined generally as any person who beneficially owns 15% or more of the outstanding voting stock of such corporation or any person affiliated with such person) for a period of three years following the time that such stockholder became an interested stockholder, unless: 
		

		
			 
		

			
	
			
				 ·
			

			
	
			
			prior to such time, the board of directors of such corporation approved either the business combination or the transaction that resulted in the stockholder becoming an interested stockholder; 

		
			﻿
		

			
	
			
				 ·
			

			
	
			
			upon consummation of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of such corporation outstanding at the time the transaction commenced (excluding for purposes of determining the voting stock of such corporation outstanding (but not the outstanding voting stock owned by the interested stockholder) those shares owned (A) by persons who are directors and also officers of such corporation and (B) by employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer); or 

		
			﻿
		

			
	
			
				 ·
			

			
	
			
			on or subsequent to such time the stockholder became interested, the business combination is approved by the board of directors of such corporation and authorized at a meeting of stockholders by the affirmative vote of at least two-thirds of the outstanding voting stock of such corporation not owned by the interested stockholder.

		
			﻿
		

		
			Section 203 could delay, defer or prevent a change in control of our company.
		

		
			﻿
		

		
			Certificate of Incorporation and Bylaw Provisions
		

		
			﻿
		

		
			Various provisions contained in our certificate of incorporation and bylaws could delay or discourage some transactions involving an actual or potential change in control of us or our management and may limit the ability of stockholders to remove current management or approve transactions that stockholders may deem to be in their best interests and could adversely affect the price of our common stock. These provisions:
		

		

		

		 

 

		﻿
		

			
	
			
				 ·
			

			
	
			
			authorize our board of directors to establish one or more series of undesignated preferred stock, the terms of which can be determined by the board of directors at the time of issuance;

		
			﻿
		

			
	
			
				 ·
			

			
	
			
			authorize our board of directors to issue any authorized but unissued shares of common stock.  Subject to applicable stockholder approval requirements under the listing rules of the Nasdaq Stock Market LLC, such issuances could be utilized for a variety of corporate purposes, including future offerings to raise additional capital, acquisitions and employee benefit plans. The existence of authorized but unissued and unreserved common stock could render more difficult or discourage an attempt to obtain control of us by means of a proxy contest, tender offer, merger or otherwise;

		
			﻿
		

			
	
			
				 ·
			

			
	
			
			divide our board of directors into three classes of directors, with each class serving a staggered three-year term. As the classification of the board of directors generally increases the difficulty of replacing a majority of the directors, it may tend to discourage a third party from making a tender offer or otherwise attempting to obtain control of us and may make it more difficult to change the composition of the board of directors;

		
			﻿
		

			
	
			
				 ·
			

			
	
			
			prohibit cumulative voting by stockholders in the election of directors. Under cumulative voting, a minority stockholder holding a sufficient percentage of a class of shares may be able to ensure the election of one or more directors;

		
			﻿
		

			
	
			
				 ·
			

			
	
			
			require that any action required or permitted to be taken by our stockholders must be effected at a duly called annual or special meeting of stockholders and may not be effected by any consent in writing;

		
			﻿
		

			
	
			
				 ·
			

			
	
			
			state that special meetings of our stockholders may be called only by (i) the Chairman of the board of directors, (ii) our Chief Executive Officer, (iii) the board of directors pursuant to a resolution adopted by a majority of the total number of then authorized directors (regardless of any vacancies then in existence), or (iv) the Chairman of the board of directors or our secretary upon written request of the holders of not less than 10% of our outstanding voting stock;

		
			﻿
		

			
	
			
				 ·
			

			
	
			
			establish advance notice requirements for submitting nominations for election to the board of directors and for proposing matters that can be acted upon by stockholders at a meeting;

		
			﻿
		

			
	
			
				 ·
			

			
	
			
			provide that certain provisions of our certificate of incorporation can be amended only by a vote of at least two thirds of the voting power of all then outstanding shares of voting stock, and that our bylaws can be amended only by (i) a vote of at least two thirds of the voting power of all then outstanding shares of voting stock or (ii) our board of directors;

		
			﻿
		

			
	
			
				 ·
			

			
	
			
			allow our directors, not our stockholders, to fill vacancies on our board of directors; and

		
			﻿
		

			
	
			
				 ·
			

			
	
			
			provide that the authorized number of directors may be changed only by resolution of the board of directors.

		
			﻿
		

		
			Majority Voting for Election of Directors
		

		
			﻿
		

		
			Our bylaws require, in uncontested elections, that each director be elected by the majority of votes cast with respect to such director. This means that the number of shares voted “for” a director nominee must exceed the number of shares affirmatively voted “against” the nominee in order for that nominee to be elected. If an incumbent director fails to receive a majority of the votes cast in an uncontested election, such incumbent 
		

		 

 

		director shall tender his or her resignation for consideration by our corporate governance and nominating committee. The corporate governance and nominating committee will then consider any such tendered resignation and will make a recommendation to the board of directors as to whether such tendered resignation should be accepted, rejected, or whether other action should be taken. The board of directors, within 90 days after the date on which certification of the stockholder vote on the election of directors is made, will publicly disclose (by press release and filing an appropriate disclosure with the SEC) its decision regarding the resignation and, if such resignation is rejected, the rationale behind the decision. The corporate governance and nominating committee in making its recommendation and the board of directors in making its decision each may consider any factors or other information that they consider appropriate and relevant. A plurality voting standard will continue to apply in the event of a Contested Election (as defined in our bylaws).
		

		
			﻿
		

		
			Limitation on Liability and Indemnification of Directors and Officers 
		

		
			﻿
		

		
			Our bylaws provide that our directors and officers will be indemnified by us to the fullest extent authorized by the DGCL or any other applicable law, against all expenses incurred in connection with their service for or on our behalf. 
		

		
			﻿
		

		
			In addition to the indemnification provided by our bylaws, we have entered into agreements to indemnify our directors and certain executive officers. These agreements, among other things and subject to certain standards to be met, require us to indemnify these directors and officers for certain expenses, including attorneys’ fees and other expenses, judgments, penalties, fines and amounts paid in settlement actually and reasonably incurred by any such person or on such persons’ behalf in any action, suit, arbitration, alternate dispute resolution mechanism, investigation, inquiry, administrative hearing or any other actual, threatened or completed proceeding, including any action by or in our right, arising out of that person’s services as an officer or director of us, or by reason of the fact that such person is or was serving at our request as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise. These agreements also require us to advance expenses to these officers and directors for defending any such action or proceeding, subject to an undertaking to repay such amounts if it is ultimately determined that such director or officer was not entitled to be indemnified for such expenses. 
		

		
			﻿
		

		
			Insofar as indemnification for liabilities arising under the Securities Act of 1933, as amended (the “Securities Act”) may be permitted to our directors, officers or controlling persons pursuant to the foregoing provisions, or otherwise, we have been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable. 
		

		
			﻿
		

		
			The Nasdaq Global Select Market
		

		
			﻿
		

		
			Our common stock is listed on The Nasdaq Global Select Market under the trading symbol RECN.
		

		
			﻿
		

		
			Transfer Agent and Registrar
		

		
			﻿
		

		
			The transfer agent and registrar for our common stock is American Stock Transfer & Trust.
		

		
			﻿

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00298-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00298-of-00352.parquet"}]]